579 related articles for article (PubMed ID: 26645203)
1. Childhood Blood Lead Levels and Symptoms of Attention Deficit Hyperactivity Disorder (ADHD): A Cross-Sectional Study of Mexican Children.
Huang S; Hu H; Sánchez BN; Peterson KE; Ettinger AS; Lamadrid-Figueroa H; Schnaas L; Mercado-García A; Wright RO; Basu N; Cantonwine DE; Hernández-Avila M; Téllez-Rojo MM
Environ Health Perspect; 2016 Jun; 124(6):868-74. PubMed ID: 26645203
[TBL] [Abstract][Full Text] [Related]
2. Measured Prenatal and Estimated Postnatal Levels of Polychlorinated Biphenyls (PCBs) and ADHD-Related Behaviors in 8-Year-Old Children.
Verner MA; Hart JE; Sagiv SK; Bellinger DC; Altshul LM; Korrick SA
Environ Health Perspect; 2015 Sep; 123(9):888-94. PubMed ID: 25769180
[TBL] [Abstract][Full Text] [Related]
3. Environmental lead exposure and attention deficit/hyperactivity disorder symptom domains in a community sample of South Korean school-age children.
Hong SB; Im MH; Kim JW; Park EJ; Shin MS; Kim BN; Yoo HJ; Cho IH; Bhang SY; Hong YC; Cho SC
Environ Health Perspect; 2015 Mar; 123(3):271-6. PubMed ID: 25280233
[TBL] [Abstract][Full Text] [Related]
4. Low blood levels of lead and mercury and symptoms of attention deficit hyperactivity in children: a report of the children's health and environment research (CHEER).
Ha M; Kwon HJ; Lim MH; Jee YK; Hong YC; Leem JH; Sakong J; Bae JM; Hong SJ; Roh YM; Jo SJ
Neurotoxicology; 2009 Jan; 30(1):31-6. PubMed ID: 19100765
[TBL] [Abstract][Full Text] [Related]
5. Attention-deficit/hyperactivity symptoms in preschool children from an e-waste recycling town: assessment by the parent report derived from DSM-IV.
Zhang R; Huo X; Ho G; Chen X; Wang H; Wang T; Ma L
BMC Pediatr; 2015 May; 15():51. PubMed ID: 25939992
[TBL] [Abstract][Full Text] [Related]
6. Confirmation and extension of association of blood lead with attention-deficit/hyperactivity disorder (ADHD) and ADHD symptom domains at population-typical exposure levels.
Nigg JT; Nikolas M; Mark Knottnerus G; Cavanagh K; Friderici K
J Child Psychol Psychiatry; 2010 Jan; 51(1):58-65. PubMed ID: 19941632
[TBL] [Abstract][Full Text] [Related]
7. Prenatal fluoride exposure and attention deficit hyperactivity disorder (ADHD) symptoms in children at 6-12 years of age in Mexico City.
Bashash M; Marchand M; Hu H; Till C; Martinez-Mier EA; Sanchez BN; Basu N; Peterson KE; Green R; Schnaas L; Mercado-García A; Hernández-Avila M; Téllez-Rojo MM
Environ Int; 2018 Dec; 121(Pt 1):658-666. PubMed ID: 30316181
[TBL] [Abstract][Full Text] [Related]
8. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
9. Low blood lead levels associated with clinically diagnosed attention-deficit/hyperactivity disorder and mediated by weak cognitive control.
Nigg JT; Knottnerus GM; Martel MM; Nikolas M; Cavanagh K; Karmaus W; Rappley MD
Biol Psychiatry; 2008 Feb; 63(3):325-31. PubMed ID: 17868654
[TBL] [Abstract][Full Text] [Related]
10. Maternal Mild Thyroid Hormone Insufficiency in Early Pregnancy and Attention-Deficit/Hyperactivity Disorder Symptoms in Children.
Modesto T; Tiemeier H; Peeters RP; Jaddoe VW; Hofman A; Verhulst FC; Ghassabian A
JAMA Pediatr; 2015 Sep; 169(9):838-45. PubMed ID: 26146876
[TBL] [Abstract][Full Text] [Related]
11. Attention deficit hyperactivity disorder and its association with heavy metals in children from northern Chile.
Muñoz MP; Rubilar P; Valdés M; Muñoz-Quezada MT; Gómez A; Saavedra M; Iglesias V
Int J Hyg Environ Health; 2020 May; 226():113483. PubMed ID: 32106053
[TBL] [Abstract][Full Text] [Related]
12. Blood lead, bone lead and child attention-deficit-hyperactivity-disorder-like behavior.
Lin Y; Huang L; Xu J; Specht AJ; Yan C; Geng H; Shen X; Nie LH; Hu H
Sci Total Environ; 2019 Apr; 659():161-167. PubMed ID: 30597466
[TBL] [Abstract][Full Text] [Related]
13. Prenatal methylmercury, postnatal lead exposure, and evidence of attention deficit/hyperactivity disorder among Inuit children in Arctic Québec.
Boucher O; Jacobson SW; Plusquellec P; Dewailly E; Ayotte P; Forget-Dubois N; Jacobson JL; Muckle G
Environ Health Perspect; 2012 Oct; 120(10):1456-61. PubMed ID: 23008274
[TBL] [Abstract][Full Text] [Related]
14. [Blood and urine lead levels in children with attention deficit hyperactivity disorder].
Sánchez-Villegas Mdel C; Cortés-Vargas A; Hidalgo-Luna RG; Alam-Escamilla DA; Vargas-García VM; Loría-Castellanos J
Rev Med Inst Mex Seguro Soc; 2014; 52(1):20-7. PubMed ID: 24625479
[TBL] [Abstract][Full Text] [Related]
15. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
[TBL] [Abstract][Full Text] [Related]
16. Environmental exposure to lead, but not other neurotoxic metals, relates to core elements of ADHD in Romanian children: performance and questionnaire data.
Nicolescu R; Petcu C; Cordeanu A; Fabritius K; Schlumpf M; Krebs R; Krämer U; Winneke G
Environ Res; 2010 Jul; 110(5):476-83. PubMed ID: 20434143
[TBL] [Abstract][Full Text] [Related]
17. Increased risk of attention-deficit/hyperactivity disorder associated with exposure to organophosphate pesticide in Taiwanese children.
Yu CJ; Du JC; Chiou HC; Chung MY; Yang W; Chen YS; Fuh MR; Chien LC; Hwang B; Chen ML
Andrology; 2016 Jul; 4(4):695-705. PubMed ID: 27070915
[TBL] [Abstract][Full Text] [Related]
18. Case-control study of blood lead levels and attention deficit hyperactivity disorder in Chinese children.
Wang HL; Chen XT; Yang B; Ma FL; Wang S; Tang ML; Hao MG; Ruan DY
Environ Health Perspect; 2008 Oct; 116(10):1401-6. PubMed ID: 18941585
[TBL] [Abstract][Full Text] [Related]
19. Association between blood lead levels (<5 μg/dL) and inattention-hyperactivity and neurocognitive profiles in school-aged Korean children.
Kim Y; Cho SC; Kim BN; Hong YC; Shin MS; Yoo HJ; Kim JW; Bhang SY
Sci Total Environ; 2010 Nov; 408(23):5737-43. PubMed ID: 20825975
[TBL] [Abstract][Full Text] [Related]
20. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
Biederman J; Pliszka SR
J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
